Viking Global Investors — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Ecovative grows whole-cut meat alternatives and other materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.
BiotechFoodTechNew MaterialsGreen Island, US
Gavin McIntyre(Executive Officer, Director)Eben Bayer(Executive Officer, Director)
BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)
Co-investorsBreakout LabsBreakout VenturesStray Dog CapitalAiiM PartnersFootPrint CoalitionStandard Investments
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+7 more
Keboola provides a data platform that helps organizations turn data into reliable decisions.
AI & Machine LearningClimate TechCloud ComputingData & InfrastructureFintechSaaS
Co-investorsPresto VenturesReflex CapitalTCF Capital
BiotechWaltham, US
ILISSA LARIMORE(Executive Officer)GERARDO TOLEDO(Executive Officer, Director)ERIC SCHOTT(Executive Officer)
BoardANULA JAYASURIYA(Director)inMATTHEW WALKER(Director)NEAL BHADKAMKAR(Director)in
Co-investorsOlive Tree CapitalRising TideBold Capital PartnersDigitalDx VenturesS2G Investments
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.